Latest news with #AED2.26B
Yahoo
2 days ago
- Business
- Yahoo
Discovering Opportunities: Duran Dogan Basim ve Ambalaj Sanayi And 2 Other Middle Eastern Penny Stocks
As most Gulf markets rise, with Dubai's main index reaching a 17-year high, the Middle East continues to capture investor attention with its robust economic indicators and steady oil prices. Though the term 'penny stocks' might feel like a relic of past market eras, the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials. Name Share Price Market Cap Financial Health Rating Terminal X Online (TASE:TRX) ₪4.37 ₪555.01M ★★★★★★ Menara Ventures Xl - Limited Partnership (TASE:MNRA) ₪2.719 ₪12.49M ★★★★★★ Thob Al Aseel (SASE:4012) SAR4.02 SAR1.6B ★★★★★★ Alarum Technologies (TASE:ALAR) ₪2.811 ₪197.21M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.14 AED2.26B ★★★★★★ Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY1.79 TRY1.93B ★★★★★☆ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.13 AED361.51M ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.41 AED10.25B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.726 AED441.59M ★★★★★★ Tgi Infrastructures (TASE:TGI) ₪2.335 ₪173.59M ★★★★★★ Click here to see the full list of 94 stocks from our Middle Eastern Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Duran Dogan Basim ve Ambalaj Sanayi A.S., along with its subsidiaries, offers packaging products across Turkey and various international markets including Europe, the United States, the Middle East, Africa, and the Asia Pacific; it has a market cap of TRY1.59 billion. Operations: The company's revenue is primarily generated from its Packaging & Containers segment, amounting to TRY1.90 billion. Market Cap: TRY1.58B Duran Dogan Basim ve Ambalaj Sanayi A.S. has shown a reduction in debt levels, with its debt to equity ratio decreasing significantly over the past five years. Despite being unprofitable, the company has managed to reduce its losses annually by 13.4%. Its short-term assets comfortably cover both short and long-term liabilities, indicating a strong liquidity position. However, high net debt to equity remains a concern. Recent earnings reports highlight declining sales and continued net losses, although these losses have narrowed slightly compared to previous periods. The company's dividend is not well covered by earnings, suggesting potential sustainability issues. Dive into the specifics of Duran Dogan Basim ve Ambalaj Sanayi here with our thorough balance sheet health report. Explore historical data to track Duran Dogan Basim ve Ambalaj Sanayi's performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Matricelf Ltd is a biotechnology company focused on developing a platform for autologous tissue engineering to address various medical conditions, with a market cap of ₪44.55 million. Operations: Matricelf Ltd does not currently report any revenue segments. Market Cap: ₪44.55M Matricelf Ltd, a pre-revenue biotechnology company with a market cap of ₪44.55 million, recently announced a collaboration with Cellino to advance personalized spinal cord injury treatments. This partnership leverages Cellino's Nebula™ technology and Matricelf's regenerative approach to create scalable therapies. Despite being debt-free and having short-term assets exceeding liabilities, Matricelf faces challenges due to its unprofitability and limited cash runway of less than a year. The management team is experienced, but the board is relatively new. An IND application is planned for next year, aiming to initiate clinical trials for their innovative therapy. Navigate through the intricacies of Matricelf with our comprehensive balance sheet health report here. Gain insights into Matricelf's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Ratio Petroleum Energy - Limited Partnership is involved in the exploration, development, and production of oil and gas, with a market cap of ₪62.95 million. Operations: Ratio Petroleum Energy - Limited Partnership has not reported any revenue segments. Market Cap: ₪62.95M Ratio Petroleum Energy - Limited Partnership, with a market cap of ₪62.95 million, is pre-revenue and faces challenges due to its unprofitability and negative return on equity. The company reported a net loss of US$4.18 million for 2024, an improvement from the previous year's larger losses. Despite having no debt and short-term assets exceeding liabilities, its cash runway is limited to less than a year if growth continues at historical rates. The board's average tenure suggests experience; however, the management's experience remains unclear. Share price volatility has decreased but remains high compared to other Israeli stocks. Click here to discover the nuances of Ratio Petroleum Energy - Limited Partnership with our detailed analytical financial health report. Review our historical performance report to gain insights into Ratio Petroleum Energy - Limited Partnership's track record. Embark on your investment journey to our 94 Middle Eastern Penny Stocks selection here. Searching for a Fresh Perspective? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:DURDO TASE:MTLF and TASE:RTPT. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
15-04-2025
- Business
- Yahoo
Middle Eastern Penny Stocks With Market Caps Over US$0
Most Gulf markets have recently experienced gains, supported by easing trade tensions following U.S. tariff exemptions on certain electronics, which has positively influenced indices across the region. For investors interested in exploring beyond the well-known companies, penny stocks—despite their somewhat outdated name—remain a relevant area of interest. These smaller or newer companies often possess solid financial foundations and potential for significant returns, offering intriguing opportunities for those willing to explore them further. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.04 SAR1.62B ★★★★★★ Keir International (SASE:9542) SAR3.93 SAR471.6M ★★★★★☆ Alarum Technologies (TASE:ALAR) ₪2.782 ₪192.91M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.949 ₪2.95B ★★★★★☆ Tarya Israel (TASE:TRA) ₪0.578 ₪171.58M ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.173 ₪161.55M ★★★★★★ Union Properties (DFM:UPP) AED0.523 AED2.26B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.735 AED450.11M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.02 AED2.06B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.44 AED10.37B ★★★★☆☆ Click here to see the full list of 96 stocks from our Middle Eastern Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Apex Investment PSC manufactures, distributes, and sells clinkers and cement products in the United Arab Emirates and internationally, with a market cap of AED14.50 billion. Operations: The company's revenue is primarily derived from its Catering segment at AED595.66 million, followed by Manufacturing at AED235.34 million, Facility Management Services at AED106.16 million, and Contracting at AED38.01 million within the United Arab Emirates and beyond. Market Cap: AED14.5B Apex Investment PSC has shown a significant turnaround by becoming profitable in the past year, reporting net income of AED75.64 million for 2024 compared to a net loss the previous year. With sales reaching AED852.85 million, the company's primary revenue streams are its Catering and Manufacturing segments. Apex's balance sheet is strong with no debt and short-term assets exceeding both short and long-term liabilities, providing financial stability. However, its earnings were impacted by a large one-off loss of AED57.9 million, and its Return on Equity remains low at 3.8%. The stock has experienced high volatility recently but maintains stable weekly volatility over the past year. Navigate through the intricacies of Apex Investment PSC with our comprehensive balance sheet health report here. Assess Apex Investment PSC's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Ihlas Holding A.S. operates in construction and real estate, media, manufacturing and trading, as well as healthcare and education sectors both in Turkey and internationally, with a market cap of TRY3.34 billion. Operations: The company's revenue is primarily derived from marketing (TRY4.22 billion), media (TRY2.29 billion), and construction (TRY1.88 billion) sectors. Market Cap: TRY3.34B Ihlas Holding A.S. has demonstrated financial resilience despite reporting a net loss of TRY1.38 billion for 2024, compared to a net income the previous year. The company's debt management is commendable, with its debt-to-equity ratio significantly reduced to 4.9% over five years and more cash on hand than total debt. Short-term assets of TRY13.7 billion cover both short and long-term liabilities, indicating robust liquidity. However, Ihlas remains unprofitable with a negative return on equity of -18.34%. Management stability is evident with an experienced team averaging 13.3 years in tenure, though share price volatility persists recently. Click here and access our complete financial health analysis report to understand the dynamics of Ihlas Holding. Evaluate Ihlas Holding's historical performance by accessing our past performance report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Imed Infinity Medical-Limited Partnership is a research and development partnership that invests in medical field projects, particularly in digital health, with a market cap of ₪3.65 million. Operations: Imed Infinity Medical-Limited Partnership has not reported any revenue segments. Market Cap: ₪3.65M Imed Infinity Medical-Limited Partnership, with a market cap of ₪3.65 million, is a pre-revenue entity focused on digital health projects. Despite being debt-free and having short-term assets ($896K) that exceed liabilities ($112K), the company remains unprofitable with losses increasing by 15.8% annually over five years. Recent earnings results show an improvement in net loss to US$0.575 million from US$1.77 million the previous year, reflecting reduced basic and diluted loss per share from continuing operations at US$0.14 compared to US$0.44 prior year-end December 2024, indicating some cost management progress amidst ongoing challenges. Dive into the specifics of Imed Infinity Medical-Limited Partnership here with our thorough balance sheet health report. Examine Imed Infinity Medical-Limited Partnership's past performance report to understand how it has performed in prior years. Click through to start exploring the rest of the 93 Middle Eastern Penny Stocks now. Ready To Venture Into Other Investment Styles? These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:APEX IBSE:IHLAS and TASE:IMED. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
04-04-2025
- Business
- Yahoo
Hub Girisim Sermayesi Yatirim Ortakligi Leads 3 Middle Eastern Penny Stocks To Watch
The Middle Eastern stock markets have recently faced downward pressure, influenced by global trade tensions and declining oil prices. Despite these challenges, certain investment opportunities remain appealing, particularly in the realm of penny stocks. Although the term "penny stocks" might seem outdated, these smaller or newer companies can offer significant growth potential at lower price points when they possess strong financials and clear growth trajectories. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.13 SAR1.65B ★★★★★★ Keir International (SASE:9542) SAR4.40 SAR528M ★★★★★☆ Alarum Technologies (TASE:ALAR) ₪2.401 ₪166.49M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.914 ₪2.84B ★★★★★☆ Tarya Israel (TASE:TRA) ₪0.596 ₪176.93M ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.208 ₪164.15M ★★★★★★ Union Properties (DFM:UPP) AED0.529 AED2.26B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.767 AED466.53M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.02 AED2.08B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.35 AED10.03B ★★★★☆☆ Click here to see the full list of 96 stocks from our Middle Eastern Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Hub Girisim Sermayesi Yatirim Ortakligi A.S. operates as a venture capital investment company with a market cap of TRY487.20 million. Operations: Hub Girisim Sermayesi Yatirim Ortakligi A.S. has not reported any specific revenue segments. Market Cap: TRY487.2M Hub Girisim Sermayesi Yatirim Ortakligi A.S., with a market cap of TRY487.20 million, is pre-revenue, generating less than US$1m in revenue. Despite being unprofitable, the company benefits from a strong cash position, ensuring a runway exceeding three years due to positive free cash flow. It operates without debt and has short-term assets (TRY17.5M) surpassing both its long-term liabilities (TRY266.6K) and short-term liabilities (TRY8.8M). The board's average tenure of 3.6 years suggests experience, while shareholders have not faced significant dilution recently despite ongoing losses increasing by 24.3% annually over five years. Click here and access our complete financial health analysis report to understand the dynamics of Hub Girisim Sermayesi Yatirim Ortakligi. Understand Hub Girisim Sermayesi Yatirim Ortakligi's track record by examining our performance history report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Big Tech 50 R&D-Limited Partnership focuses on investing in technology companies in Israel, with a market cap of ₪17.58 million. Operations: Big Tech 50 R&D-Limited Partnership has not reported any revenue segments. Market Cap: ₪17.58M Big Tech 50 R&D-Limited Partnership, with a market cap of ₪17.58 million, is pre-revenue and reported negative revenue of US$5.22 million for 2024. Despite being unprofitable, the company has no debt and maintains a strong cash runway exceeding three years based on current free cash flow. Its short-term assets of US$2.8 million comfortably cover short-term liabilities of US$99K, while the board's average tenure stands at 4.1 years, indicating experience. However, earnings have declined significantly over five years with increased losses and high share price volatility persists in recent months. Get an in-depth perspective on Big Tech 50 R&D-Limited Partnership's performance by reading our balance sheet health report here. Gain insights into Big Tech 50 R&D-Limited Partnership's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: SavorEat Ltd. is a company that specializes in cellulose-based meat substitutes, offering products designed to mimic the eating experience of real meat, with a market cap of ₪5.26 million. Operations: SavorEat Ltd. has not reported any specific revenue segments at this time. Market Cap: ₪5.26M SavorEat Ltd., with a market cap of ₪5.26 million, is pre-revenue, reporting less than US$1 million in revenue. Despite being unprofitable, the company has no debt and maintains a cash runway exceeding one year based on current free cash flow. The board's average tenure of 5.2 years suggests experience, while short-term assets of ₪11.3 million surpass short-term liabilities of ₪1.2 million comfortably. Recent earnings results showed a reduced net loss of ILS 10.7 million for 2024 compared to the previous year's ILS 13.26 million, indicating some improvement despite ongoing challenges in profitability and growth expectations. Unlock comprehensive insights into our analysis of SavorEat stock in this financial health report. Learn about SavorEat's historical performance here. Explore the 96 names from our Middle Eastern Penny Stocks screener here. Ready To Venture Into Other Investment Styles? Uncover 11 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:HUBVC TASE:BIGT and TASE:SVRT. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
04-04-2025
- Business
- Yahoo
3 Middle Eastern Penny Stocks With Market Caps Under US$400M
The Middle Eastern stock markets have recently faced downward pressure, influenced by global trade tensions and a decline in oil prices. Despite these challenges, certain investment opportunities remain attractive, particularly in the realm of penny stocks. Although the term 'penny stock' might seem outdated, it continues to represent smaller or newer companies that can offer substantial value when backed by strong financials and growth potential. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.13 SAR1.65B ★★★★★★ Keir International (SASE:9542) SAR4.40 SAR528M ★★★★★☆ Alarum Technologies (TASE:ALAR) ₪2.401 ₪166.49M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.914 ₪2.84B ★★★★★☆ Tarya Israel (TASE:TRA) ₪0.596 ₪176.93M ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.208 ₪164.15M ★★★★★★ Union Properties (DFM:UPP) AED0.529 AED2.26B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.767 AED466.53M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.02 AED2.08B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.35 AED10.03B ★★★★☆☆ Click here to see the full list of 96 stocks from our Middle Eastern Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Islamic Arab Insurance (Salama) PJSC, operating with its subsidiaries, offers a variety of general, family, health, and auto takaful solutions across Africa and Asia with a market cap of AED358.95 million. Operations: The company's revenue is primarily derived from General Takaful at AED820.65 million and Family Takaful at AED225.72 million. Market Cap: AED358.95M Islamic Arab Insurance (Salama) PJSC, with a market cap of AED358.95 million, recently reported a net income of AED13.09 million for 2024, marking a turnaround from the previous year's loss of AED158.39 million. The company operates debt-free, alleviating concerns about interest coverage and debt management but faces challenges with long-term liabilities exceeding short-term assets by AED1.74 billion. Despite stable weekly volatility at 3%, Salama's return on equity remains low at 7.4%. A new CEO was appointed in March 2025, potentially signaling strategic shifts amid its evolving board dynamics and recent profitability improvements. Click to explore a detailed breakdown of our findings in Islamic Arab Insurance (Salama) PJSC's financial health report. Assess Islamic Arab Insurance (Salama) PJSC's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Al-Baha Investment and Development Company, along with its subsidiaries, focuses on managing and leasing residential and non-residential real estate in Saudi Arabia, with a market cap of SAR851.35 million. Operations: The company generates revenue solely from its operations in Saudi Arabia, amounting to SAR18.10 million. Market Cap: SAR851.35M Al-Baha Investment and Development Company, with a market cap of SAR851.35 million, has demonstrated significant earnings growth of 139.6% over the past year, surpassing its five-year average and industry benchmarks. Despite this growth, the company faces challenges with short-term assets not covering both long-term (SAR8.9M) and short-term liabilities (SAR28.1M). It remains debt-free, which alleviates concerns about interest payments but highlights liquidity issues. The company's net profit margin improved to 46.3%, yet its return on equity is low at 3.8%. Recent shareholder meetings suggest potential strategic adjustments amid high share price volatility. Dive into the specifics of Al-Baha Investment and Development here with our thorough balance sheet health report. Learn about Al-Baha Investment and Development's historical performance here. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Fitaihi Holding Group operates in Saudi Arabia, offering gold, jewelry, and luxury products, with a market cap of SAR1.20 billion. Operations: The company's revenue is entirely generated from its operations in Saudi Arabia, amounting to SAR67.94 million. Market Cap: SAR1.2B Fitaihi Holding Group, with a market cap of SAR1.20 billion, has shown impressive earnings growth of 178.7% over the past year, significantly outpacing its five-year average and industry performance. The company reported sales of SAR67.94 million for 2024, up from SAR59.71 million in 2023, while net income rose to SAR14.52 million from SAR5.21 million the previous year. Despite high share price volatility and low return on equity at 3.1%, Fitaihi's strong asset position covers both short-term and long-term liabilities comfortably, supported by more cash than debt and stable profit margins at 21.4%. Jump into the full analysis health report here for a deeper understanding of Fitaihi Holding Group. Understand Fitaihi Holding Group's track record by examining our performance history report. Click this link to deep-dive into the 96 companies within our Middle Eastern Penny Stocks screener. Seeking Other Investments? These 11 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include DFM:SALAMA SASE:4130 and SASE:4180. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
